<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Helix</title>
    <link rel="stylesheet" href="/css/index.css">
    <script defer src="/script/common.js"></script>
</head>

<body>
    <header>
        <div class="container header-container">
            <div class="header-logo">
                <a href="#"><img src="../img/icons/logo.svg" alt="logo image"></a>
            </div>

            <div class="header-nav">
                <ul class="header-nav_list">
                    <li><a href="#">Population Health</a></li>
                    <li><a href="#">DNA Test</a></li>
                    <li><a href="#">Register Kit</a></li>
                    <li><a href="#">Sign In</a></li>
                </ul>
            </div>

            <div class="header-cart">
                <button class="header-cart-btn" id="header-cart-button"></button>
            </div>
        </div>
    </header>

    <div class="content" id="content">

        <div class="banner">
            <div class="container">
                <div class="banner-wrapper">
                    <div class="banner-text">
                        <h1 class="banner-text_title">
                            The Exome+<span>®</span>assay
                        </h1>
                        <span class="banner-text_subtitle">
                            Get the performance of a targeted panel, the breadth of a microarray,
                            and the completeness of an exome — all from one assay.
                        </span>
                    </div>
                </div>
            </div>
        </div>

        <div class="tabs">
            <div class="container">
                <div class="tabs-wrapper">
                    <div class="tabs-text">
                        <div class="tabs-text_title">
                            Bringing the benefits of multiple assays into one
                        </div>
                        <div class="tabs-text_subtitle">
                            Helix’s Exome+<span>®</span>assay has been carefully
                            optimized to provide the benefits of lcWGS,
                            whole exome sequencing, microarrays, and targeted panels — all in one assay.
                        </div>
                    </div>

                    <div class="tabs-links">
                        <button class="tab-link tab-link-active" data-tab="0">Targeted Panels</button>
                        <button class="tab-link" data-tab="1">Whole Exome Sequencing</button>
                        <button class="tab-link" data-tab="2">lcWGS and Microarrays</button>
                    </div>

                    <div class="tabs-content-wrapper">
                        <div class="tabs-content" data-show="0">
                            <div class="tabs-content_text">
                                <h2 class="tabs-content_text_title">Targeted Panels</h2>
                                <p>Panels are often used in clinical settings because
                                    they’re low cost and provide high quality coverage of
                                    specific, pre-defined genomic regions of interest. While
                                    useful in certain settings, such assays are limited by their narrow focus.</p>
                                <p>With ≥ 99.5% call rate across ~600 genes relevant to many
                                    disease states, the Exome+ assay enables you to run multiple
                                    panel-grade analyses with a single sample.</p>
                            </div>
                            <div class="tabs-content_diagrams">
                                <img src="/img/icons/diagram1.svg" alt="diagram Targeted Panels">
                            </div>
                        </div>

                        <div class="tabs-content tabs-content-hidden" data-show="1">
                            <div class="tabs-content_text">
                                <h2 class="tabs-content_text_title">lcWGS and Microarrays</h2>
                                <p>Inherited susceptibility to common, complex diseases may be 
                                    caused by rare, pathogenic variants (“monogenic”) or by the 
                                    cumulative effect of numerous common variants (“polygenic”). 
                                    Comprehensive genome interpretation should enable assessment for 
                                    both monogenic and polygenic components of inherited risk. </p>
                                <p>The traditional approach requires two distinct genetic testing 
                                    technologies—high coverage sequencing of known genes to detect 
                                    monogenic variants and a genome-wide genotyping array followed 
                                    by imputation to calculate genome-wide polygenic scores (GPSs).</p>
                            </div>
                            <div class="tabs-content_diagrams">
                                <img src="/img/icons/diagram2.svg" alt="diagram Whole Exome Sequencing">
                            </div>
                        </div>

                        <div class="tabs-content tabs-content-hidden" data-show="2">
                            <div class="tabs-content_text">
                                <h2 class="tabs-content_text_title">Whole Exome Sequencing</h2>
                                <p>The original sequencing technology, called Sanger 
                                    sequencing (named after the scientist who developed it, 
                                    Frederick Sanger), was a breakthrough that helped scientists 
                                    determine the human genetic code, but it is time-consuming 
                                    and expensive. The Sanger method has been automated to make 
                                    it faster and is still used in laboratories today to 
                                    sequence short pieces of DNA, but it would take years to 
                                    sequence all of a person's DNA (known as the person's genome). </p>
                                <p>>Next-generation sequencing has sped up the process (taking 
                                    only days to weeks to sequence a human genome) while reducing the cost.</p>
                            </div>
                            <div class="tabs-content_diagrams">
                                <img src="/img/icons/diagram3.svg" alt="diagram lcWGS and Microarrays">
                            </div>
                        </div>
                    </div>

                </div>
            </div>
        </div>

        <div class="faq">
            <div class="container">
                <div class="faq-wrapper">
                    <div class="faq-text">
                        <div class="faq-text_title">
                            A future proofed assay
                        </div>
                        <div class="faq-text_subtitle">
                            There are several advantages to running panels in the
                            presence of a whole exome, including flexible test design,
                            flexible re-testing, and increased functionality.
                        </div>
                    </div>

                    <div class="faqs-content-wrapper">
                        <ul class="faqs-list">
                            <li class="faq-item">
                                <div class="faq-item-visible">
                                    <h3 class="faq-item-title">Flexible test design</h3>
                                </div>
                                <div class="faq-item-hidden">
                                    <div class="faq-item-text">
                                        1) The Exome+ assay provides the flexibility needed to build
                                        a comprehensive panel that can be expanded over time. With ~20,000
                                        genes sequenced in each sample, every gene becomes a candidate for inclusion.
                                        And, while we have ensured the highest call rates across those genes that are
                                        most likely to belong to a panel, the Exome+ assay delivers high call rates for
                                        all
                                        genes beyond this core set.
                                    </div>
                                    <div class="faq-item-statistics">
                                        <div class="faq-item-statistics-top">
                                            <span class="statistics-number">20,000</span>
                                            <span>Genes sequenced in each sample</span>
                                        </div>
                                        <div class="faq-item-statistics-bottom">
                                            <span class="statistics-number">≥99.5%</span>
                                            <span>panel call rates</span>
                                        </div>
                                    </div>
                                </div>
                            </li>
                            <!--  -->
                            <li class="faq-item faq-item-hide">
                                <div class="faq-item-visible">
                                    <h3 class="faq-item-title">Sequence once, query often</h3>
                                </div>
                                <div class="faq-item-hidden">
                                    <div class="faq-item-text">
                                        2) The Exome+ assay provides the flexibility needed to build
                                        a comprehensive panel that can be expanded over time. With ~15,000
                                        genes sequenced in each sample, every gene becomes a candidate for inclusion.
                                        And, while we have ensured the highest call rates across those genes that are
                                        most likely to belong to a panel, the Exome+ assay delivers high call rates for
                                        all genes beyond this core set. With ~15,000
                                        genes sequenced in each sample, every gene becomes a candidate for inclusion.
                                    </div>
                                    <div class="faq-item-statistics">
                                        <div class="faq-item-statistics-top">
                                            <span class="statistics-number">15,000</span>
                                            <span>Genes sequenced in each sample</span>
                                        </div>
                                        <div class="faq-item-statistics-bottom">
                                            <span class="statistics-number">≥79.5%</span>
                                            <span>panel call rates</span>
                                        </div>
                                    </div>
                                </div>
                            </li>
                            <!--  -->
                            <li class="faq-item faq-item-hide">
                                <div class="faq-item-visible">
                                    <h3 class="faq-item-title">Comprehensive PGx</h3>
                                </div>
                                <div class="faq-item-hidden">
                                    <div class="faq-item-text">
                                        3) The Exome+ assay provides the flexibility needed to build
                                        a comprehensive panel that can be expanded over time. With ~10,000
                                        genes sequenced in each sample, every gene becomes a candidate for inclusion.
                                        And the Exome+ assay delivers high call rates for
                                        all genes beyond this core set.
                                    </div>
                                    <div class="faq-item-statistics">
                                        <div class="faq-item-statistics-top">
                                            <span class="statistics-number">10,000</span>
                                            <span>Genes sequenced in each sample</span>
                                        </div>
                                        <div class="faq-item-statistics-bottom">
                                            <span class="statistics-number">≥88.5%</span>
                                            <span>panel call rates</span>
                                        </div>
                                    </div>
                                </div>
                            </li>
                        </ul>
                    </div>

                </div>
            </div>
        </div>

    </div>
</body>

</html>